Clin2
NCT07587918Possibly a fitNot yet recruiting

Dietary acid and kidney health in type 2 diabetes

Type 2 DiabetesChronic Kidney Disease

Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study looks at how the acid load from your diet affects kidney function in people with type 2 diabetes and early kidney disease. It aims to see if the effect differs between men and women and between Dutch and South-Asian Surinamese people.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are older than 18 years.
  • You have type 2 diabetes and early kidney disease (stage G1-3a) with protein in your urine.
  • Your body mass index (BMI) is 25 or higher.
  • You take metformin (a diabetes medicine) at a stable dose for the last 3 months.
  • You understand Dutch well enough to read study materials.
  • You are of white European Dutch or South-Asian Surinamese background.
  • You take ACE inhibitors or angiotensin II receptor blockers (blood pressure medicines).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05888909Recruiting
Tests better diagnosis and treatment planning for kidney disease in type 2 diabetes

This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.

Beijing
NCT07434791Recruiting
Goal-directed therapy to protect kidneys and heart in diabetic kidney disease

This study tests whether a goal-directed treatment plan using several medications can lower the risk of kidney and heart problems for people with diabetes and kidney disease. It aims to help you manage your condition more effectively.

Toronto, Ontario
NCT07325201Not yet recruiting· Phase 2
Preventing dangerous blood acid buildup when using SGLT2 inhibitors for type 1 diabetes

This study tests whether using a dual continuous glucose and ketone monitor can help people with type 1 diabetes safely take a class of drugs called SGLT2 inhibitors, which may improve blood sugar control but can increase the risk of diabetic ketoacidosis (DKA). By closely monitoring changes in glucose and ketone levels, the study aims to prevent dangerous episodes while benefiting from the drug's effects.

Minneapolis, Minnesota
NCT07169786Not yet recruiting
Diet and kidney health in type 2 diabetes

This study looks at how diet affects the progression of chronic kidney disease in people with type 2 diabetes. If you join, you may receive dietary guidance to help slow kidney decline.

NCT07839208Not yet recruiting
Heart and lung health in type 2 diabetes with early kidney damage

This study looks at how diabetes may affect the heart's ability to relax and pump blood, and whether this relates to early kidney damage. If you have type 2 diabetes, or if you are healthy, you may be able to help by joining.

Asyut, Asyut Governorate
NCT07854990Not yet recruiting
Heart and kidney health in type 2 diabetes

This study looks at how heart, kidney, and weight problems affect people with type 2 diabetes. It aims to find better ways to treat these related conditions and improve overall health.

Asyut, Abutig

Hear when a new Type 2 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.